CTRI/2026/07/114062进行中（未招募）2 期
A Clinical study to evaluate the effectiveness of Gayatriyadi kasayam with Chandraprabha vati in the management of Madhumeha with special reference to Type - 2 Diabetes mellitus - NIL
Sonu Yadav0 个研究点目标入组 37 人开始时间: —最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 37
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Willing for clinical trial patients with age between 31 to 60 years patients possessing signs and symptoms of Madhumeha Freshly diagnosed confirmed case of Madhumeha on the basis of diagnostic criteria FBS 126 to 200 mg/dl and PPBS 200 to 300 mg/dl Hba1c 6.5 to 7.5
排除标准
- •Patient not willing for clinical trial and not fulfilling the criteria patient below the age of 31 years and above 60 years FBS level less than 126 mg/dl and more than 200 mg/dl PPBS level less than 200 mg/dl and more than 300 mg/dl HbA1c less than 6.5 percent and more than 7.5 percent IDDM gestational diabetes MODY LADA endrocrinopathies pregnant and lactating women
研究者
相似试验
进行中（未招募）
Unknown
Effectiveness of OjasNoor Renewal Serum for BrighteningCTRI/2026/07/114186VedaLume Private Limited, OjasNoor36
进行中（未招募）
不适用
Effectiveness of Shalmali Flower Powder with Honey and Rice Water in the Management of White Vaginal DischargeCTRI/2026/07/113985Dr. Leena50
进行中（未招募）
3 期
NN9838-7910: A research study to look at how two different doses of CagriSema and one dose of semaglutide help people living with obesity with or without type 2 diabetes lose weightNutritional, Metabolic, EndocrinePACTR202607641626021Novo Nordisk120
招募中
2 期
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progressionGlioblastoma2022-501822-39-00Philogen S.p.A.113
招募中
不适用
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease (J2A-MC-GZPR)Peripheral Arterial DiseasejRCT20312505701,205